Saffron extract has produced some of the most favourable trial results of any herbal supplement, which is itself a reason to look at the research carefully.
What is saffron?
The dried stigmas of the Crocus sativus flower, harvested by hand, which makes it the most expensive spice by weight.
Saffron extract supplements are standardised to compounds including crocin and safranal, which give it its colour and aroma.
What do people take it for?
Low mood and mild depression, which is the main use.
Appetite control and snacking, which is how it appears in some weight products.
Eye health, particularly in age related macular degeneration, where small trials exist.
What does the research show?
Meta-analyses of saffron extract for depressive symptoms have reported effects comparable to standard antidepressants in mild to moderate depression.
Those are striking findings for a herbal supplement, and they warrant scrutiny rather than acceptance.
Why does the research pattern matter?
A large proportion of saffron trials come from a small number of research groups in one country.
Trials have generally been small and short, and independent replication elsewhere is limited.
Results this consistent from a narrow research base are a pattern worth noticing rather than dismissing outright.
What dose is used?
Most trials used around 30 milligrams daily of standardised extract, split into two doses over six to eight weeks.
Why is adulteration a particular concern?
Because saffron is extremely valuable, it is among the most frequently adulterated products in the food supply.
Substitution with safflower, marigold, dyed plant material and even coloured fibres has been documented repeatedly.
Third party testing and reputable sourcing matter more here than for almost any other botanical.
What are the safety considerations?
- Very high doses are toxic, though far above supplement amounts
- Avoidance in pregnancy, since high doses have been associated with miscarriage
- Possible additive effects with antidepressants
- Effects on bleeding and on blood pressure reported
Should it replace treatment?
No. Depression is treatable, and anyone with persistent low mood should speak to a GP rather than self managing with a supplement.
Talking therapies are available through the NHS with self referral in many areas.
What should you look for?
A standardised extract, stated crocin or safranal content, and third party testing given the adulteration history.
Is it worth taking?
The evidence is more favourable than for most herbal supplements and comes from a narrow base.
Anyone considering it for mood should discuss it with a GP, particularly if already taking an antidepressant.
What is the summary?
Saffron extract is taken for low mood with unusually positive trials from a narrow research base, and adulteration is a real concern.
If you are struggling with your mood, support is available. This article is general information and not medical advice.
What does saffron illustrate?
That unusually consistent positive findings from a narrow research base warrant more scrutiny rather than less.
That is a general principle rather than a criticism of any particular study.
What should you expect?
If the trials hold up, a modest improvement in mild depressive symptoms over six to eight weeks.
Independent replication would strengthen the case considerably.
Who should be careful?
Anyone taking an antidepressant, given possible additive effects.
Pregnant women, and anyone on anticoagulants.
What should you check on a label?
Standardisation, third party testing and sourcing, all of which matter more here because of the adulteration record.
Very cheap saffron is a warning rather than a bargain.
What about the eye research?
Small trials have examined saffron in age related macular degeneration with some positive findings.
The evidence is preliminary and specific supplement formulations with trial evidence already exist for that condition.
An ophthalmologist can advise on those.
Should you take it with an antidepressant?
Not without discussing it, since additive serotonergic effects are plausible.
Anyone already in treatment should raise it with their prescriber.
Stopping prescribed treatment in favour of a supplement is not advisable.
Independent trials outside the current research base would settle this.